Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(73)
•••
Sailboatdream
X
View Profile
View Bullboard History
Comment by
Sailboatdream
on Feb 21, 2022 3:04pm
RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
compacency based on taking way too long in getting a deal done. As indicated in other posts, either Philip is chasing the "perfect" deal (letting perfect getting in the way of very
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Feb 20, 2022 11:38pm
RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Excited is the word I would use to describe Dr. T during the interview.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Feb 20, 2022 11:26pm
RE:RE:RE:RE:Vertex and Witkowski Partnership
And your comment re complacency is based on what, exactly? He seemed confident, I'll grant you that.
(73)
•••
Sailboatdream
X
View Profile
View Bullboard History
Comment by
Sailboatdream
on Feb 20, 2022 10:47pm
RE:RE:RE:Vertex and Witkowski Partnership
Agree with you BioTeck. I get uneasy when companies think they have such a head start that they get complacent. Philip seems over confident in Sernova's positioning.
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Feb 20, 2022 7:33pm
RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
It was created on 2017-06-21 but is still relevant and agree it's a positive for SVA. Not so with stem cells. Once you put them in, thats it. You cant withdraw them. Theres no kill switch. Sigilon
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 20, 2022 3:38pm
RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Not sure how old this article is but a positive for SVA until vertex announces their device. https://www.hopkinsmedicine.org/stem_cell_research/safety_ethics/are_induced_pluripotent_stem_cells_safe
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 19, 2022 11:36pm
RE:RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Only if spill and co decide to sell. Remember, everyone wants to be the man that cures diabetes. Money can't buy that legacy.
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Feb 19, 2022 10:50pm
RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Vertex is showing good results with their cells but its not a surprise the IPSC cells work. The challenge will be in immunosuppression and long term safety both of which are more probable with a
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Feb 19, 2022 10:05pm
RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Agree MS, Bio Vertex may have convinced them that there is no problems injecting into the portal vein but they still have to prove it and apart from using expermantial anticancer treatments or
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Feb 19, 2022 7:49pm
RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Bio, Where did they prove there is no concerns about no concerns for tumours ? The premise of a device is so that the cells maybe be retrievable because in the past stem cells went to areas and
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 19, 2022 6:40pm
RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Only if the injected stem cell islets cause IBMIR ( instant blood-mediated inflammatory reaction) would the pouch prove useful as you can only inject into the liver a couple times before you
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 19, 2022 6:34pm
RE:RE:RE:RE:Vertex and Witkowski Partnership
They proved there is no concern for tumors that's why they are allowed to inject the cells without a device. Could be why we aren't getting a deal, any cell line suppliers probably thinking
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Feb 19, 2022 6:12pm
RE:RE:RE:Vertex and Witkowski Partnership
They have some major hurdles to overcome if they plan to go with the Portal vein route. When injecting straight into frontline immune tissue, immune protection will be more
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 19, 2022 2:57pm
RE:RE:Vertex and Witkowski Partnership
They are proving their stem cells work while they get preclinical sorted for their device. With sernova paving the way for device approval, it'll make their life easier to get a human trial going
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >